Full Text View
Tabular View
No Study Results Posted
Related Studies
Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants (DACUS)
This study has been completed.
Study NCT00438230   Information provided by Azienda Ospedaliera Universitaria Policlinico

First Received on February 20, 2007.   Last Updated on February 21, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Deep Vein Thrombosis
Additional conditions recognized in this trial
Thrombosis
Venous Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Vascular Diseases
Interventions listed in this trial
Warfarin
Additional drug interventions recognized in this trial
Anticoagulants
More general drug interventions related to this trial
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Azienda Ospedaliera Universitaria Policlinico


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services